🇺🇸 Prochlorperazine 10mg in United States

92 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Death — 18 reports (19.57%)
  2. Diarrhoea — 14 reports (15.22%)
  3. Nausea — 12 reports (13.04%)
  4. Disease Progression — 10 reports (10.87%)
  5. Fatigue — 9 reports (9.78%)
  6. Vomiting — 8 reports (8.7%)
  7. Decreased Appetite — 7 reports (7.61%)
  8. Hospitalisation — 6 reports (6.52%)
  9. Dehydration — 4 reports (4.35%)
  10. Dizziness — 4 reports (4.35%)

Source database →

Prochlorperazine 10mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Prochlorperazine 10mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Prochlorperazine 10mg in United States?

Albert Einstein Healthcare Network is the originator. The local marketing authorisation holder may differ — check the official source linked above.